[go: up one dir, main page]

ITMI912237A0 - Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono - Google Patents

Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono

Info

Publication number
ITMI912237A0
ITMI912237A0 IT91MI2237A ITMI912237A ITMI912237A0 IT MI912237 A0 ITMI912237 A0 IT MI912237A0 IT 91MI2237 A IT91MI2237 A IT 91MI2237A IT MI912237 A ITMI912237 A IT MI912237A IT MI912237 A0 ITMI912237 A0 IT MI912237A0
Authority
IT
Italy
Prior art keywords
geneserin
derivatives
contain
preparation
pharmaceutical compositions
Prior art date
Application number
IT91MI2237A
Other languages
English (en)
Inventor
Paolo Chiesi
Canale Maurizio Del
Vittorino Servadio
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI912237A0 publication Critical patent/ITMI912237A0/it
Priority to ITMI912237A priority Critical patent/IT1251166B/it
Priority to ES92916772T priority patent/ES2101858T3/es
Priority to KR1019940700410A priority patent/KR100225927B1/ko
Priority to US08/193,154 priority patent/US5538968A/en
Priority to PCT/EP1992/001762 priority patent/WO1993003041A1/en
Priority to AT92916772T priority patent/ATE151426T1/de
Priority to CA002115250A priority patent/CA2115250A1/en
Priority to EP92916772A priority patent/EP0599890B1/en
Priority to JP50327893A priority patent/JP3172185B2/ja
Priority to CZ94262A priority patent/CZ281018B6/cs
Priority to DE69218949T priority patent/DE69218949T2/de
Priority to HK98106098.1A priority patent/HK1006714B/en
Priority to HU9400353A priority patent/HU222774B1/hu
Priority to AU23876/92A priority patent/AU659865B2/en
Priority to DK92916772.4T priority patent/DK0599890T3/da
Priority to NZ243869A priority patent/NZ243869A/en
Priority to ZA925903A priority patent/ZA925903B/xx
Publication of ITMI912237A1 publication Critical patent/ITMI912237A1/it
Priority to FI940573A priority patent/FI107532B/fi
Priority to NO940415A priority patent/NO303175B1/no
Application granted granted Critical
Publication of IT1251166B publication Critical patent/IT1251166B/it
Priority to GR970401476T priority patent/GR3023838T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITMI912237A 1991-08-09 1991-08-09 Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono IT1251166B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITMI912237A IT1251166B (it) 1991-08-09 1991-08-09 Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
DE69218949T DE69218949T2 (de) 1991-08-09 1992-08-04 Generserin-derivate als cholinesterase-hemmer
HU9400353A HU222774B1 (hu) 1991-08-09 1992-08-04 Kolinészteráz-inhibitor hatású geneszerinszármazékok és ezeket tartalmazó gyógyszerkészítmények
US08/193,154 US5538968A (en) 1991-08-09 1992-08-04 Geneserine derivatives processes as cholinesterase inhibitors
PCT/EP1992/001762 WO1993003041A1 (en) 1991-08-09 1992-08-04 Geneserine derivatives as cholinesterase inhibitors
AT92916772T ATE151426T1 (de) 1991-08-09 1992-08-04 Generserin-derivate als cholinesterase-hemmer
CA002115250A CA2115250A1 (en) 1991-08-09 1992-08-04 Geneserine derivatives as cholinesterase inhibitors
EP92916772A EP0599890B1 (en) 1991-08-09 1992-08-04 Geneserine derivatives as cholinesterase inhibitors
JP50327893A JP3172185B2 (ja) 1991-08-09 1992-08-04 コリンエステラーゼ阻害剤としてのゲネセリン誘導体
CZ94262A CZ281018B6 (cs) 1991-08-09 1992-08-04 Deriváty geneserinu a farmaceutické prostředky s jejich obsahem
ES92916772T ES2101858T3 (es) 1991-08-09 1992-08-04 Derivados de geneserina como inhibidores de colinesterasa.
HK98106098.1A HK1006714B (en) 1991-08-09 1992-08-04 Geneserine derivatives as cholinesterase inhibitors
KR1019940700410A KR100225927B1 (ko) 1991-08-09 1992-08-04 콜린에스테라제 저해제로서의 제네세린 유도체
AU23876/92A AU659865B2 (en) 1991-08-09 1992-08-04 Geneserine derivatives as cholinesterase inhibitors
DK92916772.4T DK0599890T3 (da) 1991-08-09 1992-08-04 Geneserinderivater som cholinesteraseinhibitorer
NZ243869A NZ243869A (en) 1991-08-09 1992-08-06 Geneserine derivatives and pharmaceutical compositions thereof
ZA925903A ZA925903B (en) 1991-08-09 1992-08-06 Geneserine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
FI940573A FI107532B (fi) 1991-08-09 1994-02-08 Menetelmä lääkeaineena käyttökelpoisten geneseriinijohdannaisten valmistamiseksi
NO940415A NO303175B1 (no) 1991-08-09 1994-02-08 Geneserinderivater som kolinesterase-hemmere
GR970401476T GR3023838T3 (en) 1991-08-09 1997-06-19 Geneserine derivatives as cholinesterase inhibitors.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912237A IT1251166B (it) 1991-08-09 1991-08-09 Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI912237A0 true ITMI912237A0 (it) 1991-08-09
ITMI912237A1 ITMI912237A1 (it) 1993-02-09
IT1251166B IT1251166B (it) 1995-05-04

Family

ID=11360556

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912237A IT1251166B (it) 1991-08-09 1991-08-09 Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono

Country Status (19)

Country Link
US (1) US5538968A (it)
EP (1) EP0599890B1 (it)
JP (1) JP3172185B2 (it)
KR (1) KR100225927B1 (it)
AT (1) ATE151426T1 (it)
AU (1) AU659865B2 (it)
CA (1) CA2115250A1 (it)
CZ (1) CZ281018B6 (it)
DE (1) DE69218949T2 (it)
DK (1) DK0599890T3 (it)
ES (1) ES2101858T3 (it)
FI (1) FI107532B (it)
GR (1) GR3023838T3 (it)
HU (1) HU222774B1 (it)
IT (1) IT1251166B (it)
NO (1) NO303175B1 (it)
NZ (1) NZ243869A (it)
WO (1) WO1993003041A1 (it)
ZA (1) ZA925903B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1273349B (it) * 1994-02-28 1997-07-08 Getters Spa Visualizzatore piatto ad emissione di campo contenente un getter e procedimento per il suo ottenimento
BR9815237A (pt) * 1997-10-10 2000-10-31 Chiesi Farma Spa Processo para preparação de derivados de aminocarbonil de geneserolina que possuem atividade anticolinesterase seletiva no cérebro
DE19853487A1 (de) * 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
CZ304198B6 (cs) * 2001-01-12 2013-12-27 Fumapharm Ag Amidy kyseliny fumarové
SI1663197T1 (sl) 2003-09-09 2008-06-30 Biogen Idec Internat Gmbh Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme
EP2314571A3 (en) * 2003-10-21 2011-08-31 CoLucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
CA2677241A1 (en) * 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
PL2137537T3 (pl) 2007-02-08 2013-10-31 Biogen Ma Inc Kompozycje i zastosowania do leczenia stwardnienia rozsianego
US20100130607A1 (en) * 2007-02-08 2010-05-27 Ralf Gold Neuroprotection in demyelinating diseases
CN101795683A (zh) * 2007-07-18 2010-08-04 科露西德医药品公司 用于促进警醒症的方法
US8593728B2 (en) * 2009-02-19 2013-11-26 Toyota Motor Engineering & Manufacturing North America, Inc. Multilayer photonic structures
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
JP6373353B2 (ja) 2013-03-14 2018-08-15 アルカーメス ファーマ アイルランド リミテッド フマル酸エステルのプロドラッグおよび種々の疾患の治療におけるその使用
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
ES2881081T3 (es) 2013-03-15 2021-11-26 Agenebio Inc Procedimientos y composiciones para mejorar la función cognitiva
WO2015127450A1 (en) 2014-02-24 2015-08-27 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374908A1 (fr) * 1976-12-21 1978-07-21 Theranol Lab Medicament constitue par l'association optimale d'une substance vagomimetique, le salicylate d'amine-oxyde d'eserine, et d'une substance potentialisant la secretion gastrique, le chlorhydrate d'acide glutamique
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina

Also Published As

Publication number Publication date
NO940415L (no) 1994-04-06
HU222774B1 (hu) 2003-10-28
KR100225927B1 (ko) 1999-10-15
FI940573A0 (fi) 1994-02-08
NO940415D0 (no) 1994-02-08
JP3172185B2 (ja) 2001-06-04
CZ281018B6 (cs) 1996-05-15
CA2115250A1 (en) 1993-02-18
NZ243869A (en) 1994-03-25
IT1251166B (it) 1995-05-04
EP0599890A1 (en) 1994-06-08
ZA925903B (en) 1993-04-28
FI107532B (fi) 2001-08-31
ITMI912237A1 (it) 1993-02-09
DK0599890T3 (da) 1997-10-20
AU659865B2 (en) 1995-06-01
HU9400353D0 (en) 1994-06-28
GR3023838T3 (en) 1997-09-30
HK1006714A1 (en) 1999-03-12
CZ26294A3 (en) 1994-07-13
US5538968A (en) 1996-07-23
ES2101858T3 (es) 1997-07-16
JPH06509572A (ja) 1994-10-27
DE69218949T2 (de) 1997-09-18
FI940573L (fi) 1994-03-28
DE69218949D1 (de) 1997-05-15
WO1993003041A1 (en) 1993-02-18
HUT70414A (en) 1995-10-30
AU2387692A (en) 1993-03-02
EP0599890B1 (en) 1997-04-09
NO303175B1 (no) 1998-06-08
ATE151426T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
ITMI912237A0 (it) Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono
FI934274A7 (fi) N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset
FI922958L (fi) Farmaceutisk sammansaettning
FI981777A0 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
IT8848714A0 (it) Derivati di adenosina, composizioni farmaceutiche che li contengono erelativo procedimento di preparazione ed appplicazione
ITMI910404A0 (it) Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
BR9200058A (pt) Composto e composicao farmaceutica
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
FI943645L (fi) Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
FI960487L (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
IT9022154A0 (it) Derivati poliaminopirrolcarbossiamidici, processi di preparazione e composizioni farmaceutiche che li contengono
IT8667976A0 (it) Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT9021305A0 (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
IT8948610A0 (it) Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono
ITFI920134A1 (it) Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
IT8847912A0 (it) Derivati di forskolina, loro procedimento ed intermedi di preparazione, loro applicazione in qualita'di medicamenti e composizioni farmaceutiche che li contengono
IT9021880A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1257276B (it) Derivati tienopirimidinonacrilici, loro preparazione e composizioni farmaceutiche che li contengono
IT1216120B (it) Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
IT8823183A0 (it) Derivati diossazocinici, loro preparazione e composizioni che li contengono
IT8922399A0 (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960826